Aktie A1C829 CHINA BOTANIC PHARMACEUTICAL INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen China Botanic Pharmaceutical Inc. Other OTC

Aktien

A1C829

US16890Y1047

CBPI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Fuss Brands Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024
Fuss Brands Corp. Reports Earnings Results for the Full Year Ended October 31, 2023
Fuss Brands Corp. Announces Resignation of Issamar Ginzberg as Chief Executive Officer
Fuss Brands Corp. Announces Board Changes
Fuss Brands Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
Fuss Brands Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
Fuss Brands Corp. Reports Earnings Results for the First Quarter Ended January 31, 2023
FUSS BRANDS CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT OF OPERATIONS (form 10-K)
Fuss Brands Corp. Reports Earnings Results for the Full Year Ended October 31, 2022
FUSS BRANDS CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
Fuss Brands Corp. Receives Purchase Order from Roomwagon, LLC
Fuss Brands Corp. Auditor Raises 'Going Concern' Doubt
Fuss Brands Corp. announced that it has received $0.078 million in funding
FUSS BRANDS CORP. Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K/A)
FUSS BRANDS CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Fuss Brands Corp. Signs Licensing Agreement with Anyvention Ltd. to Acquire Intellectual Property Rights
Fuss Brands Corp. Signs Licensing Agreement with Anyvention Ltd. to Acquire Intellectual Property Rights
FUSS BRANDS CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
FUSS BRANDS CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Fuss Brands Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DR75 Aktie
  4. A1C829 Aktie
  5. Nachrichten China Botanic Pharmaceutical Inc.
  6. Andere Sprachen